1,016 filings
Page 24 of 51
8-K
ABIO
ARCA biopharma Inc
10 Dec 14
Arca Biopharma Receives Fda Orphan Drug Designation for RNAPC2 As a Potential Treatment for Ebola
12:00am
424B4
ABIO
ARCA biopharma Inc
2 Dec 14
Prospectus supplement with pricing info
12:00am
8-K
ABIO
ARCA biopharma Inc
1 Dec 14
Arca Biopharma Announces Management Transitions
12:00am
CT ORDER
ABIO
ARCA biopharma Inc
20 Nov 14
Confidential treatment order
12:00am
424B4
ABIO
ARCA biopharma Inc
12 Nov 14
Prospectus supplement with pricing info
12:00am
10-Q
2014 Q3
ABIO
ARCA biopharma Inc
Quarterly report
12 Nov 14
12:00am
CT ORDER
ABIO
ARCA biopharma Inc
17 Sep 14
Confidential treatment order
12:00am
8-K
ABIO
ARCA biopharma Inc
18 Aug 14
Arca Biopharma Announces Health Canada Acceptance of Genetic-af Clinical Trial Application
12:00am
424B4
ABIO
ARCA biopharma Inc
18 Aug 14
Prospectus supplement with pricing info
12:00am
424B4
ABIO
ARCA biopharma Inc
14 Aug 14
Prospectus supplement with pricing info
12:00am
10-Q
2014 Q2
ABIO
ARCA biopharma Inc
Quarterly report
13 Aug 14
12:00am
CT ORDER
ABIO
ARCA biopharma Inc
27 Jun 14
Confidential treatment order
12:00am
424B4
ABIO
ARCA biopharma Inc
9 Jun 14
Prospectus supplement with pricing info
12:00am
8-K
ABIO
ARCA biopharma Inc
9 Jun 14
Robert E. Conway Elected Chairman of Arca Biopharma
12:00am
424B4
ABIO
ARCA biopharma Inc
14 May 14
Prospectus supplement with pricing info
12:00am
10-Q
2014 Q1
ABIO
ARCA biopharma Inc
Quarterly report
13 May 14
12:00am
EFFECT
ABIO
ARCA biopharma Inc
6 May 14
Notice of effectiveness
12:00am
CORRESP
ABIO
ARCA biopharma Inc
2 May 14
Correspondence with SEC
12:00am
CT ORDER
ABIO
ARCA biopharma Inc
18 Apr 14
Confidential treatment order
12:00am
DEFA14A
ABIO
ARCA biopharma Inc
15 Apr 14
Additional proxy soliciting materials
12:00am